By DAVID SHAYWITZ
“There are many years the place nothing occurs; and there are weeks the place many years occur,” stated Lenin, in all probability by no means. It’s additionally a remarkably apt characterization of the final 12 months in generative AI (genAI) — the final week specifically — which has seen the AI panorama shift so dramatically that even skeptics are actually updating their priors in a extra bullish path.
In September 2025, Anthropic, the AI firm behind Claude, launched what it described as its most succesful mannequin but, and stated it may keep on advanced coding duties for about 30 hours constantly. Reported examples together with constructing an internet app from scratch, with some runs described as producing roughly 11,000 traces of code. In January 2026, two Wall Road Journal reporters who stated they’d no programming background used Claude Code to construct and publish a Journal undertaking, and described the potential as “a breakout second for Anthropic’s coding device” and for “vibe coding” — the concept of making software program just by describing it.
Across the similar time, OpenClaw went viral as an open-source assistant that runs domestically and works via on a regular basis apps like WhatsApp, Telegram, and Slack to execute multi-step duties. The deeper shift, although, is architectural: the ecosystem is converging on open requirements for AI integration. One such commonplace referred to as MCP — the “USB-C of AI” — is now being downloaded almost 100 million occasions a month, suggesting that AI integration has moved from exploratory to operational.
Markets are watching the evolution of AI brokers into doubtlessly helpful financial actors and reacting accordingly. When Anthropic introduced plans to maneuver into high-revenue verticals — together with monetary providers, legislation, and life sciences — the Journal headline learn: “Menace of New AI Instruments Wipes $300B Off Software program and Information Shares.”
Economist Tyler Cowen noticed that this second will “go down as some type of turning level.” Derek Thompson, lengthy involved about an AI bubble, stated his worries “declined considerably” in current weeks. Heeding Wharton’s Ethan Mollick — “keep in mind, at the moment’s AI is the worst AI you’ll ever use” — traders and entrepreneurs are busily trying to find alternatives to trip this wave.
Some founders are taking their ambition to healthcare and life science, the place they see a slew of issues for which (they anticipate) genAI may be the answer, or at the least a part of it. The strategy one AI-driven startup is taking in direction of main care presents a glimpse into what such a future would possibly maintain (or maybe what contemporary hell awaits us).
Two Visions of Major Care
There may be real disaster in main care. Absurdly overburdened and comically underpaid, main care physicians have fled the occupation in droves — some to concierge practices the place (they are saying) they will present the standard of care that initially attracted them to drugs, many out of scientific follow totally. Recruiting new trainees grows tougher every year.
What’s being misplaced is captured with extraordinary energy by Dr. Lisa Rosenbaum in her NEJM podcast collection on the subject.
In a companion essay, Rosenbaum paperwork the measurable penalties when sufferers lose a main care doctor: an increase in mortality, emergency room visits, and hospitalizations, all in proportion to the connection’s period — suggesting, as she writes, “that the connection itself conferred well being advantages.” Worse, greater than three quarters of sufferers by no means kind a brand new PCP relationship after shedding one.
However Rosenbaum’s deepest concern isn’t statistical. It’s about what she calls the “good physician” phenotype — not a talent set however a mode. She describes a doctor whose hallmark was assuming duty for the totality of his sufferers’ issues. When Rosenbaum was caring for certainly one of his hospitalized sufferers, the affected person insisted she replace the physician, explaining merely: “He’ll need to know.” For Rosenbaum, having your sufferers intuit that you’d need to know — way over any high quality metric — constitutes the essence of being a great physician. A “tradition and not using a imaginative and prescient of the great physician,” she warns, “is a occupation and not using a soul.”
Her darkest fear: the system could morph into “some artificial-intelligence-enhanced triage system devoid of a relational core.”
Which is sort of precisely what physician-entrepreneur Muthu Alagappan, co-founder of Counsel Well being, aspires to ship — for the sake of sufferers. His place to begin: 100 million People don’t have a relationship with a health care provider, good or in any other case. The relational splendid Rosenbaum celebrates is already inaccessible to huge swaths of the inhabitants.
At Counsel Well being — just lately backed by a $25M Sequence A from GV and Andreessen Horowitz — AI handles the upfront info gathering and preliminary scientific reasoning, functioning, as Alagappan places it, like “a particularly sensible medical resident that’s reasoning together with them, serving up the plan and permitting them to approve or deny in a single click on.” Medical doctors see 15 to 20-plus sufferers per hour. The imaginative and prescient: main care visits costing lower than a greenback.
As Alagappan sees it “It’s exhausting to fathom a cognitive side of the follow of medication in main care {that a} know-how system is simply not higher suited to do than the human mind.”
He acknowledges that people should still be crucial for pesky, hands-on duties like wrapping an ankle or administering a vaccine, however past these, he appears to consider, the long run belongs to the machines. He anticipates “regulation will ease and enhance in order that the AI can do increasingly more.”
In Utah, the strategy pursued by a startup referred to as Doctronic suggests such regulatory change could also be nearer than we predict. The corporate’s AI prescribes renewals and not using a doctor within the loop for 190 routine drugs, at $4 per script — with a malpractice insurance coverage coverage overlaying the AI system itself, and escalation and oversight safeguards. Enlargement is already contemplated to states like Texas, Arizona and Missouri, with a nationwide roll-out into account as nicely.
Who’s in cost?
As AI capabilities compound quickly, there’s super temptation to use them wherever they match most naturally. With out intentionality, this strategy dangers quietly redefining disciplines by the duties the know-how performs nicely. As a result of AI can effectively course of signs, match protocols, and renew prescriptions, we’d begin to outline drugs as these particular duties — in a lot the identical manner that as a result of we are able to measure steps, sleep scores, and VO2 max, we’re tempted to outline well being because the optimization of dashboard metrics. As Kate Crawford astutely warned, we should not let the “affordances of the instruments change into the horizon of reality.”
This stress extends to biopharma R&D as nicely. Right here, efforts to leverage AI have succeeded in restricted domains with dense knowledge and established benchmarks, however have struggled the place the important knowledge are scarce, extremely conditional, or each — as Andreas Bender, specifically, has eloquently mentioned.
We’re at all times tempted to look the place the sunshine is. However tough as it may be to take care of give attention to what truly issues, fairly than what know-how most readily delivers, it may be carried out.
A Firm Constructed on What Issues
For a while now, I’ve argued — on this house, at KindWellHealth, and elsewhere — that genuinely enhancing human flourishing requires consideration to a few broad dimensions: physiology (motion, diet, restoration, preventive screening), company (your perception in your potential to form a greater future), and connection (the worth of significant relationships and purposeful pursuits).
The information that caught my consideration just lately was that somebody independently constructed a enterprise round precisely this framework. Unbound, a UK-based preventive well being firm working from a single just-opened location in London’s Shoreditch, describes itself as “constructed on the idea that bodily, psychological and social well being are inseparable.”
A number of design selections distinguish Unbound from the optimization-culture norm. They measure connectedness alongside biomarkers — actually assessing social connection as a scientific enter. Their medical director, Dr. Elliott Roy-Highley, frames well being as “not merely the results of inner mobile mechanics, however an emergent property of social integration, function, and communal regulation.” A espresso store replaces the ready room; group circles, run golf equipment, and artwork exhibitions aren’t wellness window-dressing however structural commitments – the social setting is handled as significant a part of the intervention.
Maybe most distinctive is a post-assessment “future self” train — an evidence-backed constructive psychology intervention that asks individuals to check their optimum future self and establish private limitations to reaching that imaginative and prescient. By strengthening the psychological connection between current and future selves, the train enhances aim readability, self-efficacy, and motivation for habits change. This course of works via narrative mechanisms — imagining, evaluating, and orienting towards personally significant targets –that translate evaluation insights into actionable well being methods.
Crucially, Unbound doesn’t reject measurement and know-how. They provide a companion app for extending connection and monitoring suggestions past the clinic; their assessments combine blood work and bodily efficiency testing alongside the emotional and social parts. As Unbound places it: “Sure, we use instruments like scientific testing — however not as a method to measure your price or push you to chase perfection. We use them to information and help a a lot larger aim: serving to you reside the life you need, with readability and confidence.” The intent: leverage science and know-how with intentionality, pointing them the place they need to be aimed, fairly than the place they’re most inclined to go.
After all, there’s a big hole between a compelling idea and improved well being. It’s potential Unbound will show to be savvy wellness advertising and marketing geared toward motivated, prosperous urbanites. The individuals who stroll into a stylish Shoreditch well being studio are already comparatively motivated and certain already drawn to purposeful engagement. The proof that this system truly improves well being, whereas theoretically grounded, stays to be seen.
However the curiosity Unbound has attracted reveals a considerable urge for food for one thing past relentless metric optimization — and there’s little of their strategy that appears particularly proprietary. The identical foundational rules — deepen connection, develop company, attend (with compassion) to physiology — all could possibly be utilized at scale by incumbents and digital platforms. Peloton, for example, has the group infrastructure and the person engagement; what it lacks is a framework that extends past leaderboards and efficiency dashboards towards one thing that may assist customers not simply carry out however flourish.
Backside Line
GenAI is advancing at a tempo that will have appeared fantastical even a 12 months in the past; the developments of the previous few weeks have pressured even seasoned skeptics to recalibrate. There may be super incentive — and good purpose — to trip this know-how wave towards compelling alternatives just like the disaster in main care. However as these capabilities compound, the central problem can be guaranteeing the know-how serves what sufferers and folks really need, fairly than permitting these must be outlined by what the know-how most readily delivers. The danger of basically decreasing well being to what will be optimized by know-how is actual, as so many tech-powered corporations in healthcare, biotech, and health exhibit. However it is usually potential to leverage know-how in service of a extra full and fewer reductive imaginative and prescient — attending to physiology, company, and real human connection — as Unbound suggests, and hopefully, many others pursue.
Dr. David Shaywitz, a physician-scientist, is a lecturer at Harvard Medical College, an adjunct fellow on the American Enterprise Institute, and founding father of KindWellHealth, an initiative centered on advancing well being via the science of company. This piece was beforehand printed on the Timmerman Report